KNOLL SYNTHROID CAMPAIGN MUST REFLECT "MATERIAL INFORMATION" IN UNPUBLISHED ARTICLE, FDA TELLS COMPANY: OPENING VOLLEY IN 1997 DEBATE ON JOURNAL REPRINTS?

Knoll's dissemination of a 1993 article on Synthroid and competing levothyroxine products is misleading because the company has not disclosed "material information" in its possession about the issue, FDA charges in a Nov. 7 letter to the company.